Effect of moxalactam on human fecal microflora. 1986

Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka

Five healthy male adults received 2 g of moxalactam every 12 h for 7 days. The alterations of fecal microflora were investigated before, during, and after treatment with moxalactam. On day 7 of treatment, the number of total bacteria was decreased in all subjects. There was marked suppression of the obligate anaerobic bacteria and enterobacteria to undetectable levels, but the counts of Streptococcus spp. and Lactobacillus spp. increased. On day 7, two subjects had Clostridium innocuum and Clostridium ramosum in their feces but not Clostridium difficile. On day 7 after treatment, the counts of Streptococcus spp., enterobacteria, Lactobacillus spp., and Clostridium spp. in all subjects were still not normal.

UI MeSH Term Description Entries
D008297 Male Males
D009070 Moxalactam Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. 1-Oxacephalosporin,6059-S,Disodium Latamoxef,Disodium Moxalactam,Festamoxin,Lamoxactam,Latamoxef,Lilly 127935,Ly-127935,Ly127935,Moxalactam Disodium,S-6059,Shiomarin,1 Oxacephalosporin,6059 S,6059S,Disodium, Moxalactam,Latamoxef, Disodium,Ly 127935,Moxalactam, Disodium,S 6059,S6059
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
January 1989, Microbiology and immunology,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
January 1990, Reviews of infectious diseases,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
December 1993, Journal of nutritional science and vitaminology,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
January 1992, Microbiology and immunology,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
January 1977, Chemotherapy,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
March 1995, The Japanese journal of antibiotics,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
October 1980, Nutrition reviews,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
August 1967, Journal of bacteriology,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
October 1992, The Japanese journal of antibiotics,
Y Benno, and N Shiragami, and K Uchida, and T Yoshida, and T Mitsuoka
January 1987, Die Nahrung,
Copied contents to your clipboard!